AbbVie
ABBV
#25
Rank
S$498.81 B
Marketcap
$282.56
Share price
-0.24%
Change (1 day)
17.22%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of December 2024 : S$4.49 Billion

According to AbbVie's latest financial reports the company has S$4.49 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$S$4.57 B-66.7%
2023-12-31$S$13.73 B-40.75%
2022-12-31$S$23.17 B11.05%
2021-12-31$S$20.86 B20.44%
2020-12-31$S$17.32 B-257.27%
2019-12-31$-S$11.02 Billion-4.52%
2018-12-31$-S$11.54 Billion-269.25%
2017-12-31$S$6.81 B1.6%
2016-12-31$S$6.70 B20.24%
2015-12-31$S$5.58 B142.44%
2014-12-31$S$2.30 B-59.56%
2013-12-31$S$5.69 B38.39%
2012-12-31$S$4.11 B-73.39%
2011-12-31$S$15.45 B-23.61%
2010-12-31$S$20.22 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$118.20 B 2,530.71%๐Ÿ‡บ๐Ÿ‡ธ USA
S$21.88 B 387.16%๐Ÿ‡บ๐Ÿ‡ธ USA
S$19.06 B 324.24%๐Ÿ‡บ๐Ÿ‡ธ USA
S$7.84 B 74.70%๐Ÿ‡บ๐Ÿ‡ธ USA
S$25.70 B 472.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.32 B 396.91%๐Ÿ‡บ๐Ÿ‡ธ USA
S$21.93 B 388.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$54.58 B 1,114.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$3.45 B-23.02%๐Ÿ‡บ๐Ÿ‡ธ USA